CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
IRUBIS GmbH is developing a novel sensor system for real-time monitoring of bioreactors used in biopharmaceutical manufacturing. This technology aims to enhance production efficiency and reduce costs, ultimately accelerating the delivery of high-quality medicines to patients.
Biopharmaceuticals are medical drugs typically produced by mammalian cells in so-called bioreactors.
It takes on average 10-15 years to bring a new drug to the market.
Biomanufacturing costs can account for up to 30% of the overall costs needed to approve a new medicine.
Currently, monitoring of bioproduction is mostly performed by using offline equipment that lacks robustness and has a reduced operational flexibility.
Bioreactors are increasingly being monitored online and on real-time by means…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
